VISTAGEN THERAPEUTICS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$5.33 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-08-12
- VISTAGEN THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-06-30 was -$5.33M, a 2894.23% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-03-31 was -$1.22M, a 519.05% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-12-31 was $88.93M.
- VISTAGEN THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-09-30 was $13.85M.
- VISTAGEN THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2021 was $101.75M.
- VISTAGEN THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2020 was -$11.75M, a 531.49% decline from fiscal 2019.
- VISTAGEN THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2019 was $2.72M, a 63.50% decline from fiscal 2018.
- VISTAGEN THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $7.46M, a 199.14% increase from fiscal 2017.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 157 month | Cash and Cash Equivalents, Period Increase (Decrease) 160 month | Cash and Cash Equivalents, Period Increase (Decrease) 163 month | Cash and Cash Equivalents, Period Increase (Decrease) 166 month | Cash and Cash Equivalents, Period Increase (Decrease) 169 month | Cash and Cash Equivalents, Period Increase (Decrease) 172 month | Cash and Cash Equivalents, Period Increase (Decrease) 175 month | Cash and Cash Equivalents, Period Increase (Decrease) 178 month | Cash and Cash Equivalents, Period Increase (Decrease) 181 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | -$5.33M 10-Q · filed 2021-08-12 | -$6.55M derived: sum of 2 quarters · filed 2021-08-12 | $82.38M derived: sum of 3 quarters · filed 2021-08-12 | $96.23M derived: sum of 4 quarters · filed 2021-08-12 | ||||||||||||
| 2021-03-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-29 | $87.71M derived: sum of 2 quarters · filed 2021-06-29 | $101.56M derived: sum of 3 quarters · filed 2021-06-29 | $101.75M 10-K · filed 2021-06-29 | ||||||||||||
| 2020-12-31 | $88.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-11 | $102.79M derived: sum of 2 quarters · filed 2021-02-11 | $102.98M 10-Q · filed 2021-02-11 | $103.27M derived: sum of 4 quarters · filed 2021-08-12 | ||||||||||||
| 2020-09-30 | $13.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12 | $14.04M 10-Q · filed 2020-11-12 | $14.34M derived: sum of 3 quarters · filed 2021-08-12 | $11.33M derived: sum of 4 quarters · filed 2021-08-12 | ||||||||||||
| 2020-06-30 | $190.80K 10-Q · filed 2021-08-12 | $482.60K derived: sum of 2 quarters · filed 2021-08-12 | -$2.53M derived: sum of 3 quarters · filed 2021-08-12 | -$6.75M derived: sum of 4 quarters · filed 2021-08-12 | ||||||||||||
| 2020-03-31 | $291.80K derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-29 | -$2.72M derived: sum of 2 quarters · filed 2021-06-29 | -$6.94M derived: sum of 3 quarters · filed 2021-06-29 | -$11.75M 10-K · filed 2021-06-29 | ||||||||||||
| 2019-12-31 | -$3.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-11 | -$7.23M derived: sum of 2 quarters · filed 2021-02-11 | -$12.04M 10-Q · filed 2021-02-11 | -$5.22M derived: sum of 4 quarters · filed 2021-02-11 | ||||||||||||
| 2019-09-30 | -$4.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12 | -$9.03M 10-Q · filed 2020-11-12 | -$2.21M derived: sum of 3 quarters · filed 2020-11-12 | -$3.76M derived: sum of 4 quarters · filed 2020-11-12 | ||||||||||||
| 2019-06-30 | -$4.80M 10-Q · filed 2020-08-13 | $2.01M derived: sum of 2 quarters · filed 2020-08-13 | $465.50K derived: sum of 3 quarters · filed 2020-08-13 | $1.07M derived: sum of 4 quarters · filed 2020-08-13 | ||||||||||||
| 2019-03-31 | $6.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-29 | $5.27M derived: sum of 2 quarters · filed 2020-06-29 | $5.87M derived: sum of 3 quarters · filed 2020-06-29 | $2.72M 10-K · filed 2020-06-29 | ||||||||||||
| 2018-12-31 | -$1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-13 | -$945.90K derived: sum of 2 quarters · filed 2020-02-13 | -$4.09M 10-Q · filed 2020-02-13 | -$6.75M derived: sum of 4 quarters · filed 2020-02-13 | ||||||||||||
| 2018-09-30 | $600.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | -$2.55M 10-Q · filed 2019-11-07 | -$5.20M derived: sum of 3 quarters · filed 2019-11-07 | $6.07M derived: sum of 4 quarters · filed 2019-11-07 | ||||||||||||
| 2018-06-30 | -$3.15M 10-Q · filed 2019-08-13 | -$5.80M derived: sum of 2 quarters · filed 2019-08-13 | $5.47M derived: sum of 3 quarters · filed 2019-08-13 | $5.60M derived: sum of 4 quarters · filed 2019-08-13 | ||||||||||||
| 2018-03-31 | -$2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-25 | $8.61M derived: sum of 2 quarters · filed 2019-06-25 | $8.75M derived: sum of 3 quarters · filed 2019-06-25 | $7.46M 10-K · filed 2019-06-25 | ||||||||||||
| 2017-12-31 | $11.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-12 | $11.40M derived: sum of 2 quarters · filed 2019-02-12 | $10.11M 10-Q · filed 2019-02-12 | $8.66M derived: sum of 4 quarters · filed 2019-02-12 | ||||||||||||
| 2017-09-30 | $136.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-10-29 | -$1.16M 10-Q · filed 2018-10-29 | -$2.61M derived: sum of 3 quarters · filed 2018-10-29 | -$4.49M derived: sum of 4 quarters · filed 2018-10-29 | ||||||||||||
| 2017-06-30 | -$1.29M 10-Q · filed 2018-08-14 | -$2.74M derived: sum of 2 quarters · filed 2018-08-14 | -$4.63M derived: sum of 3 quarters · filed 2018-08-14 | -$6.87M derived: sum of 4 quarters · filed 2018-08-14 | ||||||||||||
| 2017-03-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-26 | -$3.34M derived: sum of 2 quarters · filed 2018-06-26 | -$5.58M derived: sum of 3 quarters · filed 2018-06-26 | $2.49M 10-K · filed 2018-06-26 | ||||||||||||
| 2016-12-31 | -$1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-12 | -$4.13M derived: sum of 2 quarters · filed 2018-02-12 | $3.94M 10-Q · filed 2018-02-12 | $3.21M derived: sum of 4 quarters · filed 2018-02-12 | ||||||||||||
| 2016-09-30 | -$2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-09 | $5.83M 10-Q · filed 2017-11-09 | $5.10M derived: sum of 3 quarters · filed 2017-11-09 | $5.56M derived: sum of 4 quarters · filed 2017-11-09 | ||||||||||||
| 2016-06-30 | $8.07M 10-Q · filed 2017-08-14 | $7.34M derived: sum of 2 quarters · filed 2017-08-14 | $7.81M derived: sum of 3 quarters · filed 2017-08-14 | $8.38M derived: sum of 4 quarters · filed 2017-08-14 | ||||||||||||
| 2016-03-31 | -$729.90K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-29 | -$265.50K derived: sum of 2 quarters · filed 2017-06-29 | $307.50K derived: sum of 3 quarters · filed 2017-06-29 | $358.50K 10-K · filed 2017-06-29 | ||||||||||||
| 2015-12-31 | $464.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-13 | $1.04M derived: sum of 2 quarters · filed 2017-02-13 | $1.09M 10-Q · filed 2017-02-13 | $1.15M derived: sum of 4 quarters · filed 2017-02-13 | ||||||||||||
| 2015-09-30 | $573.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-14 | $624.00K 10-Q · filed 2016-11-14 | $680.80K derived: sum of 3 quarters · filed 2016-11-14 | |||||||||||||
| 2015-06-30 | $51.00K 10-Q · filed 2016-08-12 | $107.80K derived: sum of 2 quarters · filed 2016-08-12 | ||||||||||||||
| 2015-03-31 | $56.80K derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-24 | $70.00K 10-K · filed 2016-06-24 | ||||||||||||||
| 2014-12-31 | $13.20K 10-Q · filed 2016-02-16 | |||||||||||||||
| 2014-06-30 | $400.70K 10-Q · filed 2015-08-14 | $380.00K derived: sum of 2 quarters · filed 2015-08-14 | $394.20K derived: sum of 3 quarters · filed 2015-08-14 | $310.90K derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||
| 2014-03-31 | -$20.70K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-29 | -$6.50K derived: sum of 2 quarters · filed 2015-06-29 | -$89.80K derived: sum of 3 quarters · filed 2015-06-29 | -$638.10K 10-K · filed 2015-06-29 | ||||||||||||
| 2013-12-31 | $14.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-17 | -$69.10K derived: sum of 2 quarters · filed 2015-02-17 | -$617.40K 10-Q · filed 2015-02-17 | -$3.50K derived: sum of 4 quarters · filed 2015-02-17 | $20.70K 10-Q · filed 2014-02-14 | |||||||||||
| 2013-09-30 | -$83.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-19 | -$631.60K 10-Q · filed 2014-11-19 | -$17.70K derived: sum of 3 quarters · filed 2014-11-19 | -$6.90K derived: sum of 4 quarters · filed 2014-11-19 | $6.50K 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | -$548.30K 10-Q · filed 2014-08-12 | $65.60K derived: sum of 2 quarters · filed 2014-08-12 | $76.40K derived: sum of 3 quarters · filed 2014-08-12 | $58.10K derived: sum of 4 quarters · filed 2014-08-12 | $89.80K 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $613.90K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-25 | $624.70K derived: sum of 2 quarters · filed 2014-06-25 | $606.40K derived: sum of 3 quarters · filed 2014-06-25 | $557.10K 10-K · filed 2014-06-25 | $638.10K 10-K · filed 2013-07-18 | |||||||||||
| 2012-12-31 | $10.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14 | -$7.50K derived: sum of 2 quarters · filed 2014-02-14 | -$56.80K 10-Q · filed 2014-02-14 | -$142.20K derived: sum of 4 quarters · filed 2014-02-14 | $24.20K 10-Q · filed 2013-02-14 | |||||||||||
| 2012-09-30 | -$18.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-14 | -$67.60K 10-Q · filed 2013-11-14 | -$153.00K derived: sum of 3 quarters · filed 2013-11-14 | -$81.10K derived: sum of 4 quarters · filed 2013-11-14 | $13.40K 10-Q · filed 2012-11-14 | |||||||||||
| 2012-06-30 | -$49.30K 10-Q · filed 2013-08-14 | -$134.70K derived: sum of 2 quarters · filed 2013-08-14 | -$62.80K derived: sum of 3 quarters · filed 2013-08-14 | -$910.30K derived: sum of 4 quarters · filed 2013-08-14 | $31.70K 10-Q · filed 2012-08-14 | |||||||||||
| 2012-03-31 | -$85.40K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-18 | -$13.50K derived: sum of 2 quarters · filed 2013-07-18 | -$861.00K derived: sum of 3 quarters · filed 2013-07-18 | -$58.30K 10-K · filed 2013-07-18 | $81.00K 10-K · filed 2012-07-02 | |||||||||||
| 2011-12-31 | $71.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14 | -$775.60K derived: sum of 2 quarters · filed 2013-02-14 | $27.10K 10-Q · filed 2013-02-14 | $27.08K 10-Q · filed 2012-02-14 | -$113.01K derived: sum of 4 quarters · filed 2013-02-14 | $166.42K 10-Q · filed 2012-02-14 | ||||||||||
| 2011-09-30 | -$847.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-14 | -$44.80K 10-Q · filed 2012-11-14 | -$44.82K 10-Q · filed 2011-11-14 | -$184.91K derived: sum of 3 quarters · filed 2012-11-14 | -$350.09K derived: sum of 4 quarters · filed 2012-11-14 | $94.52K 10-Q · filed 2011-11-14 | ||||||||||
| 2011-06-30 | $802.70K 10-Q · filed 2012-08-14 | $802.73K 10-Q · filed 2011-08-22 | $662.59K derived: sum of 2 quarters · filed 2012-08-14 | $497.41K derived: sum of 3 quarters · filed 2012-08-14 | $844.53K derived: sum of 4 quarters · filed 2012-08-14 | $942.08K 10-Q · filed 2011-08-22 | ||||||||||
| 2011-03-31 | -$140.11K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-02 | -$305.29K derived: sum of 2 quarters · filed 2012-07-02 | $41.83K derived: sum of 3 quarters · filed 2012-07-02 | -$61.70K 10-K · filed 2012-07-02 | ||||||||||||
| 2010-12-31 | -$165.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-14 | $181.94K derived: sum of 2 quarters · filed 2012-02-14 | $78.41K 10-Q · filed 2012-02-14 | |||||||||||||
| 2010-09-30 | $347.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-14 | $243.59K 10-Q · filed 2011-11-14 | ||||||||||||||
| 2010-06-30 | -$103.53K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |